Delivery Order SPE2DE23D0008-SPE2D626F20EF
Award Date 1/22/26
Potential Completion Date 1/26/26
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, for Natrelle Inspira SCF 695CC breast implants. The delivery order, which is classified as a child contract, is scheduled for completion by January 13, 2026, and was awarded without any set-aside designation. This award falls under Allergan's larger Indefinite Delivery/Indefinite Quantity (IDV) vehicle—specifically the $13.5...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order with economic price adjustment on January 20, 2026, for Natrelle Inspira SCX 525CC breast implants. The contract, which is a child order under a larger Indefinite Delivery/Indefinite Quantity vehicle, is scheduled for completion by January 22, 2026, and will be performed at Allergan's facility in Irvine, California. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,614.00 by the Defense Logistics Agency's Medical Supply Chain division on December 17, 2025, for Natrelle Inspira SCF 485CC breast implants. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of December 19, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order for Natrelle Inspira SSL 290CC breast implants by the Defense Logistics Agency's Medical Supply Chain division on January 14, 2026. The contract, classified as a child delivery order under a larger Indefinite Delivery vehicle, carries an ultimate completion date of January 16, 2026 and was awarded without a set-aside designation, reflecting Allergan's position as a sole-source provider of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order for Natrelle Inspira SSM 275CC breast implants by the Defense Logistics Agency's Medical Supply Chain division on December 18, 2025. This delivery order, which is a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements, carries an ultimate completion date of January 7, 2026, and will be fulfilled at the contractor's facility in Irvine, California. The contract...